mx computational software-dev

Newcastle University / CCP4

Info

Professor of Structural Biology and Anti-Cancer Drug Design at Newcastle University, and Head of Academic Structural Sciences with Cancer Research Horizons - Therapeutic Innovations. Research is on structure-based discovery of cyclin-dependent kinase (CDK) inhibitors. Member of the CCP4 Executive Committee and lead of CCP4i2, the graphical user interface to the CCP4 program suite.

Key Relationships

  • CCP4 Executive Committee member
  • CCP4i2 — lead developer
  • Stuart McNicholas — CCP4mg / Moorhen collaboration
  • Newcastle Structural Biology Laboratory

Sources